Published August 14, 2023

Adrenal Cortex Neoplasms Market Size, Trends, Report and Forecast 2023-2033 According to IMARC Group’s latest report, titled “Adrenal Cortex Neoplasms Market : Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033”,The 7 major adrenal cortex neoplasms markets are expected to exhibit a CAGR of 2.24% during 2023-2033.This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.          

What is adrenal cortex neoplasms?

Adrenal cortex neoplasms comprise a set of uncommon tumors that originate in the outer layer of the adrenal glands, located atop each kidney. These glands are instrumental in synthesizing hormones that regulate various functions, including metabolism, blood pressure, and stress response. Affected individuals may exhibit various symptoms, including abdominal discomfort, unintentional weight loss, headaches, profuse sweating, excessive hair growth (in females), elevated blood pressure, and hormonal imbalances.

Other manifestations may include a sensation of fullness, breathing difficulties, muscle weakness, insomnia, decreased appetite, heart palpitations, fatigue, and nervousness. Diagnosing adrenal cortex neoplasms involves a thorough medical history, distinctive symptoms, and a physical examination. Various blood and urine tests can be employed to assess hormone levels and adrenal gland functionality. These may include dexamethasone suppression tests, 24-hour urine collection, and hormone assays. In certain scenarios, a healthcare provider may advise a tissue biopsy to conclusively confirm the diagnosis and discern the nature of the tumor. 

Request for a Free Sample Copy of this Report:

What are the growth prospects and trends in the industry?

The adrenal cortex neoplasms market is primarily propelled by the increasing instances of genetic disorders, which induce gene rearrangements that disrupt regular cellular activity and instigate tumor development. Besides this, the rising use of hormone replacement therapy, which replenishes or supplements deficient hormones such as cortisol and aldosterone in patients, is contributing to the market's growth. Moreover, the extensive adoption of whole-exome sequencing techniques, enabling the simultaneous scrutiny of multiple genes or the entire genome to identify novel mutations or fusion genes potentially causing the disease, bolsters market growth.

Additionally, the growing implementation of immune checkpoint inhibitors, which activate the immune system and enhance its ability to recognize and effectively combat cancer cells, is strengthening the market growth. Furthermore, the burgeoning popularity of targeted therapies that operate with greater precision, targeting specific molecules or receptors implicated in tumor growth, is aiding in market expansion. 

Competitive Landscape With Key Players:

The competitive landscape of the adrenal cortex neoplasms market has been studied in the report with the detailed profiles of the key players operating in the market.

Countries Covered:

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

Analysis Covered Across Each Country:

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the adrenal cortex neoplasms market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the adrenal cortex neoplasms market
• Reimbursement scenario in the market
• In-market and pipeline drugs

This report also provides a detailed analysis of the current adrenal cortex neoplasms marketed drugs and late-stage pipeline drugs.

In-Market Drugs:

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

Late-Stage Pipeline Drugs:

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures:

Key Highlights of the Report:

• Market Performance (2017-2022)
• Market Outlook (2023-2033)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group:

Chronic Bronchitis Market Free Sample Report

Chronic Urticaria Market Free Sample Report

Triple-negative Breast Cancer Market Free Sample Report

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Media Contact:

Company Name: IMARC Group

Contact Person: Elena Anderson

Email: [email protected]

Phone: +1-631-791-1145

Address: 134 N 4th St

City: Brooklyn

State: NY

Country: United States



Source link